141234-08-4 Usage
Uses
Used in Pharmaceutical Industry:
(5-METHOXY-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL)-ACETIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure allows it to be a versatile building block for the development of new drugs with potential therapeutic applications.
Used in Drug Development:
(5-METHOXY-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL)-ACETIC ACID is used as a starting material for the development of new drugs targeting various medical conditions. Its potential pharmacological activities, such as anti-inflammatory and antinociceptive properties, make it a promising candidate for the treatment of pain and inflammation-related disorders.
Used in Medicinal Chemistry Research:
(5-METHOXY-2-OXO-2,3-DIHDRO-1H-INDOL-3-YL)-ACETIC ACID is used as a research compound in medicinal chemistry to explore its potential as a lead compound for the development of novel therapeutic agents. Its unique chemical properties and bioactive potential provide a foundation for further investigation and optimization to enhance its pharmacological effects and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 141234-08-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,2,3 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 141234-08:
(8*1)+(7*4)+(6*1)+(5*2)+(4*3)+(3*4)+(2*0)+(1*8)=84
84 % 10 = 4
So 141234-08-4 is a valid CAS Registry Number.
141234-08-4Relevant academic research and scientific papers
SYNTHESIS AND CALCIUM ANTAGONIST ACTIVITY OF DIALKYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(NITROGENOUS HETEROARYL)-3,5-PYRIDINE DICARBOXYLATES
Baraldi, Pier G.,Budriesi, Roberta,Cacciari, Barbara,Chiarini, Alberto,Garuti, Laura,et al.
, p. 169 - 178 (2007/10/02)
A new series of 4-(nitrogenous heteroaryl)-1,4-dihydropyridine antagonist II - XVI were synthesized and screened for inotropic, chronotropic and calcium antagonist properties, in order to evaluate the effect on pharmacological activity of replacement of t
